Systemic PD1 antibody‐targeted treatment significantly elevated lipid peroxidation and inhibited tumor growth in immunocompetent C57 mice bearing B16‐Parkin‐knockout tumors compared with that in mice bearing B16‐WT tumors (Figure 5J–L). This evidence concerns the gene PRKN and neoplasm.